Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

June 30, 2009

Conditions
MenopauseThrombophilia
Interventions
DIETARY_SUPPLEMENT

DT56a (Femarelle) [Se-cure pharmaceuticals, Dalton, Israel]

a unique enzymatic isolate of the active complex in Tofu

Trial Locations (1)

10016

251 East 33rd Street, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT00883272 - Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women | Biotech Hunter | Biotech Hunter